Prostaglandins have been found to have a significant impact on cancer development and progression. They are involved in processes such as inflammation, cell proliferation, and immune response, all of which are critical in the context of cancer. Elevated levels of certain prostaglandins, particularly Prostaglandin E2 (PGE2), have been observed in various types of cancers, including breast cancer, colorectal cancer, and lung cancer.
